Polymorphism of eNOS and iNOS genes and chronic heart failure in patients with ischemic heart disease

Kardiologiya

Volumn 50, Issue 4, 2010, Pages 23-30

  Teplyakov, A T ^a   Shilov, S N ^a   Berezikova, E N ^a   Yakovleva, N F ^a   Mayanskaya, S D ^a   Popova, A A ^a   Luksha, E B ^a   Voronina, E N ^a   Torim, Ju Ju ^a   Karpov, R S ^a  

^a CARDIOLOGY RESEARCH INSTITUTE   (Russian Federation)

Author keywords

Chronic heart failure; Endothelial dysfunction; ENOS gene; Polymorphism of iNOS gene

Indexed keywords

DNA; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE;

AGED; ALLELE; ARTICLE; BLOOD; COMPARATIVE STUDY; ENZYMOLOGY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASODILATATION;

AGED; ALLELES; DNA; ENDOTHELIUM, VASCULAR; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; VASODILATION;

EID: 77954937182     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Katz S.D. Mechanisms and implications of endothelial dysfunction in congestive heart failure. Curr Opin Cardiol 1997;12:259-264. (Pubitemid 27252533)
2. Widder J., Bauersachs J., Fraccarollo D. et al. Endothelium-dependent and -independent vasoreactivity of rat basilar artery in chronic heart failure. J Cardiovasc Pharmacol 2000;35:515-522. (Pubitemid 30185449)
3. Sharma R., Davidoff M.N. Oxidative stress and endothelial dysfunction in heart failure. Congest Heart Fail 2002;8:165-172. (Pubitemid 34665627)
4. Dusting G.J. Nitric oxide in coronary artery disease: roles in atherosclerosis, myocardial reperfusion and heart failure. EXS 1996;76:33-55.
5. Sobrier F. Nitric oxide synthase genes among many others. Hypertension 1999;33.924-926.
6. Miyamoto Y., Saito Y., Kajiyma N. Endothelial nitric oxide synthase gene in positively associated with essential hypertension. Hypertension 1998;32:3-8. (Pubitemid 28324117)
7. Takami S., Wong Z.Y., Stebling M. Linkage analysis of endothelial nitric oxide synthase gene with human blood pressure. J Hypertension 1999;17:1431-1436. (Pubitemid 29509488)
8. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-142.
9. Wang X.L., Mahaney M.C., Sim A.S. et al. Genetic contribution of the endothelial constitute nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 1997;17:3147-3153. (Pubitemid 28016070)
10. Nadaud S., Bonnardeaux A. Lathrop M. et al. Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophis Res Commun 1994;198:1027-1033. (Pubitemid 24172800)
11. Celermajer D. S., Sorensen K. E., Gooch V. M. et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115.
12. Casas J.P., Cavalleri G.L., Bautista L.E. et al. Endothelial nitric oxide synthase gene polymorphisms and cardiovascular disease: a HuGE review. Am J Epidemiol 2006;164:921-935. (Pubitemid 44729832)
13. Persu A., Stoenoiu M. S., Messiaen T. et al. Modifier effect of eNOS in autosomal dominant polycystic kidney disease. Hum Mol Genet 2002;11:229-241. (Pubitemid 34173352)
14. Wolf B., Grabe HJ, Schluter C. et al. Endothelial nitric oxide synthase Glu298Asp gene polymorphism, blood pressure and hypertension in a general population sample. J Hypertens 2005;23:1361-1366. (Pubitemid 40933956)
15. Czamecka D., Kawecka-Jaszcz K, Stolarz K. et al. Ambulatory blood pressure, left ventricular mass and vascular phenotypes in relation to the endothelial nitric oxide synthase gene Glu298Asp and intron 4 polymorphisms in a population-based family study. J Hum Hypertens 2005;19:413-420. (Pubitemid 40662864)
16. McNamara D.M., Holubkov R., Postava L. et al. Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure. Circulation 2003;107:1598-1602. (Pubitemid 36397327)
17. Britten M.B., Schachinger V., Dimmeler S. et al. eNOS-polymorphism is associated with coronary endothelial dysfunction. Eur Heart J 1999;20:144-146.
18. Imamura A., Takahashi R., Murakami R. et al. The effects of endothelial nitric oxide synthase gene polymorphisms on endothelial function and metabolic risk factors in healthy subjects: the significance of plasma adiponectin levels. Eur J Endocrinol 2008;158:189-195. (Pubitemid 351298535)
19. Dell'Omo G, Pernio G., Pucci L. et al. Lack of association between endothelial nitric oxide synthase gene polymorphisms, microalbuminuria and endothelial dysfunction in hypertensive men. J Hypertens 2007; 25:1389-1395. (Pubitemid 46918825)
20. Kartonen J., Kauma H., Kervlnen K. et al. Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med 2002; 251:102-110. (Pubitemid 34146692)
21. Warpeha K.M., Xu W., Liu L. et al. Genotyping and functional analysis of a polymorphic (CCTTT) (n) repeat of NOS2A in diabetic retinopathy. FASEB J 1999;13:1825-1832. (Pubitemid 29473345)
22. Haywood G.A., Tsao P.S., von der Leyen H.E. et al. Exspression of inducible nitric oxide synthase in human heart failure. Circulation 1996;93:1087-1094. (Pubitemid 26087012)
23. Adams V., Nehrhoff B, Spate U. et al. Induction of iNOS expression in skeletal muscle by IL-lbeta and NFkappaB activation: an in vitro and in vivo study. Cardiovasc Res 2002;54:95-104. (Pubitemid 34327940)
24. Ferlito S. Cardiovascular diseases and nitric oxide in humans. Minerva Cardioangiol 2000;48:379-386. (Pubitemid 32066126)
25. Gealekman O., Abasst Z. Rubinstein I. et al. Role of myocardial inducible nitric oxide synthase in contractile dysfunction and beta-adrenergic hyporesponsiveness in rats with experimental volume-overload heart failure. Circulation 2002;15:236-243. (Pubitemid 34084325)
26. Wollert K.C., Fiedler B., Gambaryan S. et al. Gene transfer of cGMP-dependenet protein kines I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes. Hypertension 2002;39:87-92. (Pubitemid 34098094)
27. Arstall MA., Sawyer D.B., Fukazawa R. et al. Cytokine-mediated apoptosis in cardiac myocytes: the role of inducible nitric oxide synthase induction and peroxynitrite generation. Circ Res 1999;85:829-840. (Pubitemid 29504158)
28. Oyama J., Frantz S., Blais Jr C. Nitric oxide, cell death, and heart failure. Heart Fail Rev 2002;7:327-334. (Pubitemid 35396465)